|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: INTERLEUKIN GENETICS INC, 10-Q, EX-10.6, 2000-08-14 |
Next: PELICAN FINANCIAL INC, 10-Q, 2000-08-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THE FINANCIAL DATA SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED
FROM THE JUNE 30, 2000 BALANCE SHEET AND THE INCOME STATEMENT FOR THE SIX MONTHS
ENDED JUNE 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> JUN-30-2000
<CASH> 586,965
<SECURITIES> 4,930,800
<RECEIVABLES> 166,006
<ALLOWANCES> 47,804
<INVENTORY> 0
<CURRENT-ASSETS> 5,813,660
<PP&E> 813,592
<DEPRECIATION> 612,768
<TOTAL-ASSETS> 6,014,484
<CURRENT-LIABILITIES> 1,091,584
<BONDS> 0
0
0
<COMMON> 28,302,588
<OTHER-SE> 3,722
<TOTAL-LIABILITY-AND-EQUITY> 6,014,484
<SALES> 82,119
<TOTAL-REVENUES> 82,119
<CGS> 56,357
<TOTAL-COSTS> 1,311,099
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 6,346
<INCOME-PRETAX> (1,191,436)
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,191,436)
<EPS-BASIC> (.07)
<EPS-DILUTED> (.07)
</TABLE>
|
|